118 related articles for article (PubMed ID: 13929385)
1. [Mydocalm, a new drug to relax spastic muscles in neurological diseases].
LEHOCZKY T
Ther Hung; 1961; 9():10-3. PubMed ID: 13929385
[No Abstract] [Full Text] [Related]
2. [EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES].
LINKE H
Wien Med Wochenschr; 1964 May; 114():314-20. PubMed ID: 14232726
[No Abstract] [Full Text] [Related]
3. [Mydocalm and muscle tone].
DOBI S
Ther Hung; 1961; 9():15-8. PubMed ID: 14028214
[No Abstract] [Full Text] [Related]
4. [MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
BLONDEL F; COULEON M; COULEON H; ANNE L; CLERC G; COULOMBIER J; TRENQUALYEJP DE
Ann Med Psychol (Paris); 1964 Dec; 122():755-8. PubMed ID: 14252013
[No Abstract] [Full Text] [Related]
5. [Combined use of pharmacological preparations and a method of functional biocontrol in children with spastic forms of infantile cerebral palsy].
Shaĭtor VM; Bogdanov OV
Pediatriia; 1988; (2):111-2. PubMed ID: 3375017
[No Abstract] [Full Text] [Related]
6. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
Agarwal S; Patel T; Shah N; Patel BM
Biomed Pharmacother; 2017 Mar; 87():628-635. PubMed ID: 28086137
[TBL] [Abstract][Full Text] [Related]
7. Observations with intensive Mydocalm treatment in neurological cases.
Perényi G
Ther Hung; 1987; 35(2):66-70. PubMed ID: 3326207
[No Abstract] [Full Text] [Related]
8. Observations with higher Mydocalm doses in outpatients of the surgical department.
Huber L
Ther Hung; 1986; 34(4):243-7. PubMed ID: 3449980
[No Abstract] [Full Text] [Related]
9. Successful use of mydocalm in peripheral arterial disease.
MOLNAR L
Ther Hung; 1962; 10():10-2. PubMed ID: 13935926
[No Abstract] [Full Text] [Related]
10. Adjuvant effect of oral Mydocalm treatment with massive doses in locomotor disease patients.
Konrád K
Ther Hung; 1987; 35(3):152-5. PubMed ID: 3438877
[No Abstract] [Full Text] [Related]
11. [Treatment of spastic paralysis after neurosurgery with the preparation "Mydocalm"].
Naĭdin VL
Vopr Neirokhir; 1966; 30(6):44-5. PubMed ID: 6000723
[No Abstract] [Full Text] [Related]
12. [EVALUATION OF THE VASODILATOR EFFECT OF INTRA-ARTERIAL MYDETON IN DOGS].
KELLER L; MOLNAR G; ZULIK R
Orv Hetil; 1964 Feb; 105():250-1. PubMed ID: 14139726
[No Abstract] [Full Text] [Related]
13. [CONTRIBUTION TO THE PHARMACOLOGICAL TREATMENT OF PARTICULAR FORMS OF SPASTIC CEREBRAL DISEASE IN INFANCY].
GUASSARDO G
Clin Pediatr (Bologna); 1964 May; 46():441-5. PubMed ID: 14220897
[No Abstract] [Full Text] [Related]
14. [Tolperisone in spasticity and muscle spasm. Tolperisone in multiple sclerosis].
Nervenarzt; 1996 Jul; 67(7 Suppl Tolperison):1-4. PubMed ID: 9404528
[No Abstract] [Full Text] [Related]
15. Observations with Mydocalm in angiological practice.
Balogh A
Ther Hung; 1981; 29(2):96-99. PubMed ID: 7188136
[No Abstract] [Full Text] [Related]
16. Structural and mechanical alterations in spastic skeletal muscle.
Foran JR; Steinman S; Barash I; Chambers HG; Lieber RL
Dev Med Child Neurol; 2005 Oct; 47(10):713-7. PubMed ID: 16174321
[TBL] [Abstract][Full Text] [Related]
17. Use of Mydocalm in influencing the effect of muscle tremor on the ECG.
SOLTI F
Ther Hung; 1961; 9(3-4)():31-2. PubMed ID: 13978134
[No Abstract] [Full Text] [Related]
18. High-dose Mydocalm therapy in certain myogenous headaches.
Csányi L
Ther Hung; 1989; 37(2):115-8. PubMed ID: 2686081
[TBL] [Abstract][Full Text] [Related]
19. [ON SOME ASPECTS OF THE PROBLEM OF SPASTIC BRAIN DISEASES].
SEVERI F; CECCARELLI A
Lattante; 1963 Jun; 34():446-51. PubMed ID: 14050291
[No Abstract] [Full Text] [Related]
20. Symptomatic treatment of neurolathyrism with tolperisone HCL (Mydocalm): a randomized double blind and placebo controlled drug trial.
Melka A; Tekle-Haimanot R; Lambien F
Ethiop Med J; 1997 Apr; 35(2):77-91. PubMed ID: 9577009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
